Observational and open study in children and adolescents with severe asthma with eosinophilic phenotype treated with mepolizumab. CASAM study.
INDEPENDENT POST AUTHORIZATION STUDY
Clinical trial information
- Promoter: SPANISH SOCIETY OF PEDIATRIC PNEUMOLOGY
- Execution start: 20/10/2021
- End of execution: 30/10/2025
